Product Information
PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1144 per EA under NDC 62135080630. Its NADAC has been published 116 times since Apr 10, 2024.
Strength
45 mg/1
Manufacturer
Chartwell RX LLCNDC
62135080630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076798On Market Since
10/28/2020
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 116 times since Apr 10, 2024, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1144 per EA |
|---|---|
| All-time high | $0.1450 (Apr 10, 2024) |
| All-time low | $0.0964 (Nov 20, 2024) |
| 52-week high | $0.1305 |
| 52-week low | $0.1124 |
| Median price | $0.1213 |
| Average price | $0.1209 |
| Largest weekly change | -26.2% (Nov 20, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PIOGLITAZONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Chartwell RX LLC, is $0.1144 per EA (NDC 62135080630), effective Jun 24, 2026.
How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 21.1%. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?
Since Apr 10, 2024, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1450 (Apr 10, 2024), with a median of $0.1213 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PIOGLITAZONE HCL 45 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PIOGLITAZONE HCL 45 MG TABLET?
PIOGLITAZONE HCL 45 MG TABLET (NDC 62135080630) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification